CNS vs MAIN

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 10, 2026

CNS

33.5
AI Score
VS
MAIN Wins

MAIN

39.7
AI Score

Investment Advisor Scores

CNS

34score
Recommendation
SELL

MAIN

40score
Recommendation
SELL

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric CNS MAIN Winner
Net Income 76.58M 313.64M MAIN
ROE 44.0% 9.8% CNS
ROA 22.0% 5.2% CNS
Total Assets 348.45M 6.04B MAIN
Cash 41.23M 102.39M MAIN

Relative Price Performance (Last 90 Days)

CNS 1M: +5.0% · 3M: -15.6% MAIN 1M: +5.7% · 3M: -4.1%

Current Technical Phase

CNS

Distribution
Trim / tighten stop

Price near a flattening SMA50 (slope -5.6%) with fading momentum, RSI 49

RSI (14): 48.8 · Price: $72.33

MAIN

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 59

RSI (14): 59.0 · Price: $56.81

Fundamentals Snapshot

Metric CNS MAIN
Market Cap — —
Forward P/E 19.6 14.6
Trailing P/E 22.7 11.8
Revenue (TTM) — —
Revenue Growth 0.1% 0.0%
Gross Margin 0.5% 1.0%
Operating Margin 0.3% 0.9%
EPS 3.25 4.85
Dividend Yield 0.04% 0.05%

Frequently Asked Questions

Based on our detailed analysis, MAIN is currently the stronger investment candidate, winning 3 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.